Live attenuated simian immunodeficiency virus prevents super-infection by cloned SIVmac251 in cynomolgus monkeys. 1997

F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy.

The ability of a live attenuated simian immunodeficiency virus (SIV) to protect against challenge with cloned SIVmac251/BK28 was evaluated in four cynomolgus macaques. The intravenous infection of the C8 variant of the SIVmac251/32H virus, carrying an in-frame 12 bp deletion in the nef gene, did not affect the CD4+ and CD8+ cell counts, and a persistent infection associated with an extremely low virus burden in peripheral blood mononuclear cells (PBMCs) was established. After 40 weeks, these monkeys were challenged intravenously with a 50 MID50 dose of SIVmac251/BK28 virus grown on macaque cells. Four naive monkeys were infected as controls. Monkeys were monitored for 62 weeks following challenge. Attempts to rescue virus from either PBMCs or bone marrow from the C8-vaccinated monkeys were unsuccessful, but in two cases virus was re-isolated from lymph node cells. The presence of the SIV provirus with the C8 variant genotype maintaining its original nef deletion was shown by differential PCR in PBMCs, lymph nodes and bone marrow. Furthermore, in contrast to the control monkeys, the vaccinated monkeys showed normal levels for CD4+ and CD8+ cells, minimal lymphoid hyperplasia and no clinical signs of infection. Our results confirm that vaccination with live attenuated virus can confer protection. This appears to be dependent on the ability of the C8 variant to establish a persistent but attenuated infection which is necessary for inducing an immune response, as suggested by the persistence of a strong immune B cell memory and by the over-expression of interleukin (IL)-2, interferon-gamma and IL-15 mRNAs in PBMCs of C8-vaccinated monkeys but not in those of control monkeys.

UI MeSH Term Description Entries
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D011533 Proviruses Duplex DNA sequences in eukaryotic chromosomes, corresponding to the genome of a virus, that are transmitted from one cell generation to the next without causing lysis of the host. Proviruses are often associated with neoplastic cell transformation and are key features of retrovirus biology. Provirus
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated
D014614 Vaccines, Synthetic Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified. Antigens, Synthetic,Chemical Vaccine,Chemical Vaccines,Immunogens, Synthetic,Molecular Vaccine,Molecular Vaccines,Recombinant Vaccine,Semisynthetic Vaccine,Semisynthetic Vaccines,Synthetic Antigen,Synthetic Vaccine,Synthetic Vaccines,Vaccines, Recombinant,Synthetic Antigens,Synthetic Immunogens,Vaccines, Chemical,Vaccines, Molecular,Vaccines, Semisynthetic,Antigen, Synthetic,Recombinant Vaccines,Vaccine, Chemical,Vaccine, Molecular,Vaccine, Recombinant,Vaccine, Semisynthetic,Vaccine, Synthetic
D015163 Superinfection A frequent complication of drug therapy for microbial infection. It may result from opportunistic colonization following immunosuppression by the primary pathogen and can be influenced by the time interval between infections, microbial physiology, or host resistance. Experimental challenge and in vitro models are sometimes used in virulence and infectivity studies. Microbial Superinvasion,Superinvasion, Microbial,Microbial Superinvasions,Superinfections,Superinvasions, Microbial
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian

Related Publications

F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
January 1993, Advances in experimental medicine and biology,
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
August 1998, Current opinion in immunology,
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
January 1989, Journal of acquired immune deficiency syndromes,
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
January 1997, Nature medicine,
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
October 1999, Journal of virology,
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
December 1990, The American journal of pathology,
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
June 1990, Science (New York, N.Y.),
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
May 1997, Biochemical Society transactions,
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
October 1998, Journal of virology,
F Titti, and L Sernicola, and A Geraci, and G Panzini, and S Di Fabio, and R Belli, and F Monardo, and A Borsetti, and M T Maggiorella, and M Koanga-Mogtomo, and F Corrias, and R Zamarchi, and A Amadori, and L Chieco-Bianchi, and P Verani
September 2008, The Journal of general virology,
Copied contents to your clipboard!